Galmed Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights

Galmed Pharmaceuticals Ltd share price today is $0.5815, up 2.83%. The stock opened at $0.5821 against the previous close of $0.5835, with an intraday high of $0.5821 and low of $0.5811.

Galmed Pharmaceuticals Ltd Share Price Chart

Galmed Pharmaceuticals Ltd

us-stock
To Invest in {{usstockname}}
us-stock

Galmed Pharmaceuticals Ltd Share Price Performance

$0.5815 0.0283(2.83%) GLMD at 23 Mar 2026 01:19 PM Biotechnology
Lowest Today 0.5811
Highest Today 0.5821
Today’s Open 0.5821
Prev. Close 0.5835
52 Week High 2.34
52 Week Low 0.50
Day’s Range: Low 0.5811 High 0.5821
52-Week Range: Low 0.50 High 2.34
1 day return -
1 Week return -
1 month return +10.28
3 month return -29.59
6 month return -57.52
1 year return -66.91
3 year return -90.02
5 year return -98.91
10 year return -

Galmed Pharmaceuticals Ltd Institutional Holdings

Two Sigma Investments LLC 1.70

Citadel Advisors Llc 0.58

Two Sigma Advisers, LLC 0.48

TWO SIGMA SECURITIES, LLC 0.21

Jane Street Group LLC 0.18

Nomura Healthcare Fund Class I 0.03

UBS Group AG 0.01

BNP Paribas Arbitrage, SA 0.01

Morgan Stanley - Brokerage Accounts 0.00

Sontag Advisory LLC 0.00

TSFG, LLC 0.00

Federation des caisses Desjardins du Quebec 0.00

SBI Securities Co Ltd 0.00

Advisor Group Holdings, Inc. 0.00

Wells Fargo & Co 0.00

Dogwood Wealth Management LLC 0.00

Hanson Mcclain Inc 0.00

Schonfeld Strategic Advisors LLC 0.00

TD Waterhouse Canada Inc 0.00

Uma Financial Services Inc 0.00

ZRC WEALTH MANAGEMENT, LLC 0.00

Galmed Pharmaceuticals Ltd Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Galmed Pharmaceuticals Ltd Fundamentals

Market Cap 3.95 M

PB Ratio 0.2002

PE Ratio 0.0

Enterprise Value -8.77 M

Total Assets 18.50 M

Volume 6832

Galmed Pharmaceuticals Ltd Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-7535000 -7.5M, FY22:-18571000 -18.6M, FY21:-31948000 -31.9M, FY20:-27610000 -27.6M, FY19:-18541000 -18.5M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:-74000 -0.1M

Quarterly Net worth Q3/2025:-1892000 -1.9M, Q2/2025:-2495000 -2.5M, Q1/2025:-1104000 -1.1M, Q3/2024:-1914000 -1.9M, Q2/2024:-1119000 -1.1M

About Galmed Pharmaceuticals Ltd & investment objective

Company Information Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. Further, the company develops MyBiotics which is in pre-clinical trials for NASH and fibrosis. It has a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea; and a collaboration agreement with OnKai for its AI platform. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Ramat Gan, Israel.

Organisation Biotechnology

Employees 3

Industry Biotechnology

CEO Mr. Allen Baharaff

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Galmed Pharmaceuticals Ltd FAQs

What is the share price of Galmed Pharmaceuticals Ltd today?

The current share price of Galmed Pharmaceuticals Ltd is $0.5815.

Can I buy Galmed Pharmaceuticals Ltd shares in India?

Yes, Indian investors can buy Galmed Pharmaceuticals Ltd shares by opening an international trading and demat account with Motilal Oswal.

How to buy Galmed Pharmaceuticals Ltd shares in India?

You can easily invest in Galmed Pharmaceuticals Ltd shares from India by:

Can I buy fractional shares of Galmed Pharmaceuticals Ltd?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Galmed Pharmaceuticals Ltd?

Galmed Pharmaceuticals Ltd has a market cap of $3.95 M.

In which sector does Galmed Pharmaceuticals Ltd belong?

Galmed Pharmaceuticals Ltd operates in the Biotechnology sector.

What documents are required to invest in Galmed Pharmaceuticals Ltd stocks?

To invest, you typically need:

What is the PE and PB ratio of Galmed Pharmaceuticals Ltd?

The PE ratio of Galmed Pharmaceuticals Ltd is N/A and the PB ratio is 0.20.